Biomarkers estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) may undergo alteration on reassessment, with significant impact on management. There ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback